-
www.talkingquality.ahrq.gov/sites/default/files/wysiwyg/professionals/systems/primary-care/workforce-financing/white_paper.pdf
January 01, 2020 - such as symptom control (e.g., pain, depressive
symptoms), disease control (e.g., HIV viral load, blood … pressure), or improvements in function
(e.g., return to work, better school performance).40
Optimization
-
www.cahps.ahrq.gov/sites/default/files/wysiwyg/professionals/systems/primary-care/workforce-financing/white_paper.pdf
January 01, 2020 - such as symptom control (e.g., pain, depressive
symptoms), disease control (e.g., HIV viral load, blood … pressure), or improvements in function
(e.g., return to work, better school performance).40
Optimization
-
www.monahrq.ahrq.gov/sites/default/files/wysiwyg/professionals/systems/primary-care/workforce-financing/white_paper.pdf
January 01, 2020 - such as symptom control (e.g., pain, depressive
symptoms), disease control (e.g., HIV viral load, blood … pressure), or improvements in function
(e.g., return to work, better school performance).40
Optimization
-
www.healthcare411.ahrq.gov/sites/default/files/wysiwyg/professionals/systems/primary-care/workforce-financing/white_paper.pdf
January 01, 2020 - such as symptom control (e.g., pain, depressive
symptoms), disease control (e.g., HIV viral load, blood … pressure), or improvements in function
(e.g., return to work, better school performance).40
Optimization
-
www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/professionals/systems/primary-care/workforce-financing/white_paper.pdf
January 01, 2020 - such as symptom control (e.g., pain, depressive
symptoms), disease control (e.g., HIV viral load, blood … pressure), or improvements in function
(e.g., return to work, better school performance).40
Optimization
-
monahrq.ahrq.gov/sites/default/files/wysiwyg/professionals/systems/primary-care/workforce-financing/white_paper.pdf
January 01, 2020 - such as symptom control (e.g., pain, depressive
symptoms), disease control (e.g., HIV viral load, blood … pressure), or improvements in function
(e.g., return to work, better school performance).40
Optimization
-
healthcare411.ahrq.gov/sites/default/files/wysiwyg/professionals/systems/primary-care/workforce-financing/white_paper.pdf
January 01, 2020 - such as symptom control (e.g., pain, depressive
symptoms), disease control (e.g., HIV viral load, blood … pressure), or improvements in function
(e.g., return to work, better school performance).40
Optimization
-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/systems/primary-care/workforce-financing/white_paper.pdf
January 01, 2020 - such as symptom control (e.g., pain, depressive
symptoms), disease control (e.g., HIV viral load, blood … pressure), or improvements in function
(e.g., return to work, better school performance).40
Optimization
-
www.ahrq.gov/ncepcr/tools/workforce-financing/white-paper.html
July 01, 2019 - outcomes such as symptom control (e.g., pain, depressive symptoms), disease control (e.g., HIV viral load, blood … pressure), or improvements in function (e.g., return to work, better school performance). 40
Optimization
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/antiplatelet-treatment_disposition-comments.pdf
September 25, 2013 - However, within‐individual
differences in the pharmacodynamic effect of these “similar”
medications … If there’s no evidence of a pharmacodynamic effect of these
life-saving medications, is it reasonable … Various factors, including the CYP2C19 genotype, concomitant
medications, comorbidities, and other factors … The purpose of prescribing P2Y12‐inhibiting antiplatelet
medications is to reduce the risk for thrombosis … As previously stated, the purpose of prescribing P2Y12‐
inhibiting antiplatelet medications is to reduce
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/antiplatelet-treatment_disposition-comments.pdf
September 25, 2013 - However, within‐individual
differences in the pharmacodynamic effect of these “similar”
medications … If there’s no evidence of a pharmacodynamic effect of these
life-saving medications, is it reasonable … Various factors, including the CYP2C19 genotype, concomitant
medications, comorbidities, and other factors … The purpose of prescribing P2Y12‐inhibiting antiplatelet
medications is to reduce the risk for thrombosis … As previously stated, the purpose of prescribing P2Y12‐
inhibiting antiplatelet medications is to reduce
-
www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/sharedba.pdf
January 01, 2004 - informed about these services
or accept them as a routine part of the medical exam
(eg, screening for high blood … pressure or obesity),
making lengthy and frequent discussion unnecessary.
-
effectivehealthcare.ahrq.gov/products/disparities-quality-improvement/research-protocol
February 22, 2012 - interest include: health outcome measures (e.g. morbidity and mortality, indirect health outcomes such as blood … pressure and HbA1c); process measures (e.g. proportion of patients treated according to clinical guidelines
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/disparities-quality-improvement_research-protocol.pdf
February 23, 2012 - interest include: health outcome measures (e.g. morbidity
and mortality, indirect health outcomes such as blood … pressure and HbA1c); process
measures (e.g. proportion of patients treated according to clinical guidelines
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/disparities-quality-improvement_research-protocol.pdf
February 23, 2012 - interest include: health outcome measures (e.g. morbidity
and mortality, indirect health outcomes such as blood … pressure and HbA1c); process
measures (e.g. proportion of patients treated according to clinical guidelines
-
digital.ahrq.gov/sites/default/files/docs/citation/r01hs015274-carayon-final-report-2009.pdf
January 01, 2009 - adverse drug events are
more frequent in intensive care units primarily because of the volume of medications … After CPOE/EHR implementation, fewer medications were ordered on average in the AICU and
the CICU. … adjusting monitoring and other equipment,
transporting the patient, and obtaining and administering medications … Role of computerized
physician order entry systems in facilitating medications
errors.
-
hcup-us.ahrq.gov/db/nation/nis/APS-Def_Public_v24.pdf
March 01, 2008 - ___APS-Def_Public.book
4 0 0 C a p i t a l B o u l e v a r d • R o c k y H i l l , C T 0 6 0 6 7 • 1 - 8 0 0 - 9 9 9 - 3 7 4 7
D e f i n i t i o n s M a n u a l
PUB 3.3.2008
APS-DRGs®
ALL-PAYER SEVERITY-ADJUSTED DRG
(APS-DRGS®) ASSIGNMENT
FOR PUBLIC USE
VERSION 24
COPYRIGHT PAGE
Copyright © 2008 In…
-
www.ahrq.gov/sites/default/files/2024-07/robins-report.pdf
January 01, 2024 - The demonstrated benefits of fostering
autonomous patient motivation include greater adherence to medications … Record - EMR)
From the EMR, we collected key physiological marker variables for all patients (e.g.,
blood … pressure and HbA1c) within each physician’s panel.
-
hcup-us.ahrq.gov/toolssoftware/ccsr/PRCCSR-User-Guide-v2021-1.pdf
December 01, 2020 - PRCCSR-User-Guide-v2021-1
USER GUIDE:
CLINICAL CLASSIFICATIONS SOFTWARE REFINED
(CCSR) FOR ICD-10-PCS PROCEDURES,
v2021.1
Issued December 2020
Agency for Healthcare Research and Quality
Healthcare Cost and Utilization Project (HCUP)
Phone: (866) 290-HCUP (4287)
Email: hcup@ahrq.gov
Website: www.hcup-us…
-
preventiveservices.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/hais/tools/ambulatory-surgery/sections/sustainability/training-tools/training-tools-facnotes.docx
May 01, 2017 - AHRQ Safety Program for Ambulatory Surgery
Sustainability Module
Facilitator Notes
SAY:
This module on Sustainability helps an organization maintain and sustain a process that has worked well at a unit level. This module is meant to au…